![]() |
市场调查报告书
商品编码
1672762
血流量计市场按产品类型、应用、最终用户和地区划分Blood Flow Measurement Devices Market, By Product Type, By Application, By End User, By Geography |
预计 2025 年全球血流测量设备市场规模为 8.86 亿台,到 2032 年将达到 16.521 亿台,2025 年至 2032 年的年复合成长率(CAGR)为 9.3%。
报告范围 | 报告详细信息 | ||
---|---|---|---|
基准年 | 2024 | 2025 年市场规模 | 8.86亿美元 |
效能资料 | 2020-2024 | 预测期 | 2025-2032 |
预测期:2025 年至 2032 年复合年增长率 | 9.30% | 2032 年金额预测 | 16.521亿美元 |
由于全球心血管疾病的发生率不断上升,全球血流测量设备市场在过去几年中获得了显着的发展。患有心臟衰竭和冠状动脉疾病等心臟病的患者数量不断增加,推动了对有助于准确诊断的先进血流测量设备的需求。医疗设备产业的持续技术进步促进了非侵入性和微创血流测量解决方案的发展。数位医疗的采用和人工智慧的整合将进一步补充血流分析。据报道,正在进行的研究旨在开发可靠且价格合理的血流监测系统,这将有助于市场在 2030 年前扩大。
全球老年族群中慢性心臟疾病率的不断上升是主要的成长动力。根据世界卫生组织统计,心血管疾病每年导致全球1,700多万人死亡,占全球死亡总数的三分之一。这导致政府增加公共医疗支出,使市场参与企业受益。然而,技术先进的血流测量设备价格昂贵,在一定程度上阻碍了其广泛应用,特别是对于低收入国家的患者而言。同时,持续进行适合资源贫乏环境的高性价比产品的研究和开发正在为新兴国家创造新的机会。公共和私营部门对医疗技术开发的投资不断增加预计将进一步推动市场需求。
本报告对全球血流测量设备市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模和年复合成长率(CAGR%)。
它强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球血流计量设备市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
主要企业包括 Medistim、Cook Medical Inc.、Getinge Group、Deltex Medical Group、Transonic Systems、Compumedics、Adinstruments、Sonotec Ultraschallsensorik Halle、Biopac Systems、Moor Instruments 和 Atys Medical。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球血流测量设备市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过全球血流量计设备市场分析中使用的各种策略矩阵轻鬆做出决策。
Global Blood Flow Measurement Devices Market is estimated to be valued at USD 886.0 Mn in 2025 and is expected to reach USD 1,652.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 886.0 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 9.30% | 2032 Value Projection: | USD 1,652.1 Mn |
The global blood flow measurement devices market has been gaining significant traction over the past couple of years owing to growing prevalence of cardiovascular diseases worldwide. Rising number of patients suffering from heart conditions like heart failure, coronary artery disease etc has boosted demand for advanced blood flow measurement devices that helps achieve accurate diagnosis. Constant technological advancements in medical devices industry has led to development of non-invasive and minimally-invasive blood flow measurement solutions. Adoption of digital healthcare and integration of artificial intelligence further complements the blood flow analysis. Continuous research activities to develop reliable and affordable blood flow monitoring systems will reportedly aid the market expansion through 2030.
Growing geriatric population base suffering from chronic heart diseases around the globe acts as a key growth driver. According to WHO, cardiovascular illnesses account for over 17 million yearly deaths representing one third of all global deaths. This has prompted governments to increase public healthcare spending which benefits market players. However, expensive price tags of technologically sophisticated blood flow measurement devices especially for patients in low-income nations continues to deter their widespread adoption to some extent. On the brighter side, ongoing R&D to create cost-effective product variants suitable for resource-poor setups provides new opportunities in emerging countries. Rising investments by both public and private sectors in medical technology development is anticipated to further fuel the market demand.
This report provides in-depth analysis of the global blood flow measurement devices market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood flow measurement devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medistim, Cook Medical Inc., Getinge Group, Deltex Medical Group, Transonic Systems, Compumedics, Adinstruments, Sonotec Ultraschallsensorik Halle, Biopac Systems, Moor Instruments, and Atys Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood flow measurement devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood flow measurement devices market.
Detailed Segmentation-